Profund Advisors LLC Glaukos Corp Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Glaukos Corp stock. As of the latest transaction made, Profund Advisors LLC holds 2,776 shares of GKOS stock, worth $425,283. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,776

Previous 2,805 1.03%

Holding current value

$425,283

Previous $365,000 13.97%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$126.42 - $152.67 $3,666 - $4,427	-29 Reduced 1.03%	2,776 $416,000
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $18,974 - $22,610	167 Added 6.33%	2,805 $365,000
Q2 2024 Aug 13, 2024	SELL	$89.48 - $118.35 $12,616 - $16,687	-141 Reduced 5.07%	2,638 $312,000
Q1 2024 May 08, 2024	SELL	$76.4 - $96.33 $7,640 - $9,633	-100 Reduced 3.47%	2,779 $262,000
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $10,298 - $14,724	173 Added 6.39%	2,879 $228,000
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $11,838 - $13,524	-171 Reduced 5.94%	2,706 $203,000
Q2 2023 Aug 10, 2023	BUY	$45.44 - $71.21 $130,730 - $204,871	2,877 New	2,877 $204,000
Q2 2022 Aug 01, 2022	SELL	$34.86 - $63.77 $178,343 - $326,247	-5,116 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$44.33 - $57.82 $17,820 - $23,243	402 Added 8.53%	5,116 $296,000
Q4 2021 Feb 08, 2022	BUY	$40.27 - $56.99 $3,342 - $4,730	83 Added 1.79%	4,714 $209,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $38,940 - $69,152	-821 Reduced 15.06%	4,631 $223,000
Q2 2021 Aug 12, 2021	BUY	$73.06 - $97.7 $23,452 - $31,361	321 Added 6.26%	5,452 $464,000
Q1 2021 May 14, 2021	BUY	$70.43 - $97.42 $16,621 - $22,991	236 Added 4.82%	5,131 $431,000
Q4 2020 Feb 09, 2021	BUY	$48.9 - $75.26 $239,365 - $368,397	4,895 New	4,895 $368,000

Others Institutions Holding GKOS

# of Institutions

359

Shares Held

49.7M

Call Options Held

227K

Put Options Held

444K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Glaukos Corp Transaction History